(Q59198921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Laurent Rivory

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Andrew J. McLachlan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Christine L. Clarke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Graham J Mann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Wong M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Balleine RL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hoskins JM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Wilcken N

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Collins M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Delforce SE

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lynch K

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Schran H

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

9 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

33-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

How to calculate the dose of chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Metabolism and disposition of imatinib mesylate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Interaction of imatinib mesilate with human P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Transporters and drug therapy: implications for drug disposition and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Standard liver volume in the Caucasian population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Noninvasive tests of CYP3A enzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100201

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495881%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference